Marco Siringo | Ricerc@Sapienza

Pubblicazioni

Titolo	Pubblicato in	Anno
Real-world outcomes of Italian patients with advanced non-squamous lung cancer treated with first-line pembrolizumab plus platinum-pemetrexed	EUROPEAN JOURNAL OF CANCER	2024
Circulating Cancer-Associated Macrophage-like Cells as a Blood-Based Biomarker of Response to Immune Checkpoint Inhibitors	INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES	2024
CD137+ and regulatory T cells as independent prognostic factors of survival in advanced non-oncogene addicted NSCLC patients treated with immunotherapy as first-line	JOURNAL OF TRANSLATIONAL MEDICINE	2024
Co-Occurrence of ALK rearrangement and KRAS G12C mutation in NSCLC: Report of two cases	CURRENT PROBLEMS IN CANCER. CASE REPORTS	2024
Blood Extracellular Vesicles beyond Circulating Tumour Cells: A Valuable Risk Stratification Biomarker in High-Risk Non-Muscle-Invasive Bladder Cancer Patients	BIOMEDICINES	2024
Clinical Utility of Combined Tissue and Plasma Next-Generation Sequencing in Patients with Advanced, Treatment-Naïve, Non-Small-Cell Lung Cancer	JTO CLINICAL AND RESEARCH REPORTS	2024
Anti-PD1 therapies induce an early expansion of Ki67+CD8+ T cells in metastatic non-oncogene addicted NSCLC patients	FRONTIERS IN IMMUNOLOGY	2024
Evaluation of Efficacy of ALK Inhibitors According to Body Mass Index in ALK Rearranged NSCLC Patients—A Retrospective Observational Study	CANCERS	2023
Type 2 diabetes mellitus and efficacy outcomes from imune checkpoint blockade in patients with cancer	CLINICAL CANCER RESEARCH	2023
Comparison between liquid biopsy and tissue NGS in two cohorts of advanced NSCLC	JOURNAL OF CLINICAL ONCOLOGY	2023
Clinical utility of combined plasma and tissue NGS in patients with advanced, treatment-naïve, Non-small Cell Lung Cancer	JOURNAL OF THORACIC ONCOLOGY	2023
Future Perspectives in the Second Line Therapeutic Setting for Non-Oncogene Addicted Non-Small-Cell Lung Cancer	CANCERS	2023
Clinical Utility of Combined Plasma and Tissue NGS in Patients With Newly Diagnosed Advanced Non-Small Cell Lung Cancer	the journal of liquid biospy	2023
Selective Internal Radiation Therapy (SIRT): a new emerging role for Breast Cancer Liver Metastases	TUMORI	2023
Circulating CD137+ T cell subsets and MDCSs as immune biomarkers for response to anti-PD1 immunotherapy in NSCLC patients	AICC INTERNATIONAL MEETING – TRANSLATIONAL AND PRECISION MEDICINE	2023
Response to immunotherapy in KRAS G12C mutated NSCLC: a single-centre retrospective observational study	ONCOTARGET	2022
Advanced non-small-cell lung cancer: how to manage EGFR and HER2 exon 20 insertion mutation-positive disease	DRUGS IN CONTEXT	2022
EP08.02-046 Activity of OsimeRTInib in NSCLC with Uncommon EGFR Mutations: Retrospective Observational Multicenter Study (ARTICUNO)	JOURNAL OF THORACIC ONCOLOGY	2022
Non-small-cell lung cancer: how to manage ALK-, ROS1- and NTRK-rearranged disease	DRUGS IN CONTEXT	2022
PD-1/PD-L1 checkpoint inhibitors during late stages of life: an ad-hoc analysis from a large multicenter cohort	JOURNAL OF TRANSLATIONAL MEDICINE	2021